ASTELLAS PHARMA (Germany) Today
| YPHA Stock | EUR 9.30 0.05 0.54% |
Performance0 of 100
| Odds Of DistressLess than 9
|
ASTELLAS PHARMA is trading at 9.30 as of the 23rd of November 2024. This is a 0.54% increase since the beginning of the trading day. The stock's lowest day price was 9.3. ASTELLAS PHARMA has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for ASTELLAS PHARMA UNSPADR are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of November 2023 and ending today, the 23rd of November 2024. Click here to learn more.
Astellas Pharma Inc. engages in the manufacture, marketing, import, and export of pharmaceuticals worldwide. Astellas Pharma Inc. was founded in 1923 and is headquartered in Tokyo, Japan. ASTELLAS PHARMA operates under Drug ManufacturersGeneral classification in Germany and is traded on Frankfurt Stock Exchange. The company has 1.83 B outstanding shares. More on ASTELLAS PHARMA UNSPADR
Moving together with ASTELLAS Stock
| 0.73 | 6MK | Merck | PairCorr |
| 0.67 | AMG | Amgen Inc | PairCorr |
| 0.72 | BAYN | Bayer AG NA | PairCorr |
| 0.7 | BAYA | Bayer Aktiengesellschaft | PairCorr |
Moving against ASTELLAS Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
ASTELLAS Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. ASTELLAS PHARMA's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding ASTELLAS PHARMA or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Drug Manufacturers—General, Healthcare (View all Sectors) |
ASTELLAS PHARMA UNSPADR (YPHA) is traded on Frankfurt Exchange in Germany and employs 14,522 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 24.49 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ASTELLAS PHARMA's market, we take the total number of its shares issued and multiply it by ASTELLAS PHARMA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. ASTELLAS PHARMA UNSPADR operates under Healthcare sector and is part of Drug Manufacturers—General industry. The entity has 1.83 B outstanding shares.
ASTELLAS PHARMA UNSPADR has accumulated about 305.99 B in cash with 325.33 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 165.15, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check ASTELLAS PHARMA Probability Of Bankruptcy
ASTELLAS PHARMA UNSPADR Risk Profiles
Although ASTELLAS PHARMA's alpha and beta are two of the key measurements used to evaluate ASTELLAS PHARMA's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.3 | |||
| Standard Deviation | 1.63 | |||
| Variance | 2.66 | |||
| Risk Adjusted Performance | (0.10) |
ASTELLAS Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in ASTELLAS PHARMA without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Manager Now
Portfolio ManagerState of the art Portfolio Manager to monitor and improve performance of your invested capital |
| All Next | Launch Module |
Other Information on Investing in ASTELLAS Stock
ASTELLAS PHARMA financial ratios help investors to determine whether ASTELLAS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ASTELLAS with respect to the benefits of owning ASTELLAS PHARMA security.